BIOCOM CARD Europe Individual
> European Biotechnology Magazine Subscription
> European Biotechnology Guide
> Guide to German Biotech Companies
> conveniently accessible ePapers
> Discount for BIOCOM events for 1 person
> additional partner offers
Price: 80 Euro p.a. (incl. VAT)
Students 50% discount (subject to proof of enrolment)
BIOCOM CARD Europe Corporate
> European Biotechnology Magazine Subscription
> European Biotechnology Guide
> Guide to German Biotech Companies
> conveniently accessible ePapers
> Discount for BIOCOM events for 2 persons
> additional partner offers
Price: 120 Euro p.a. (plus VAT)
The European Biotechnology Life Sciences & Industry Magazine is only available with a BIOCOM CARD subscription.
CANCELLATION
Ordered subscriptions can be cancelled within two weeks directly at BIOCOM Interrelations GmbH. The subscription is initially valid for one calendar year and is automatically renewed every year after. The subscription can be cancelled at any time and is valid until the end of that calendar month.
For those interested in German-language publications, please see the special offers available with the BIOCOM Card D/A/CH.
Contact form
TERMS & SHIPPING
European Biotechnology Magazine is published four times a year and is only regularly available through subscription a BIOCOM Card at BIOCOM Interrelations GmbH. Failures of delivery which BIOCOM Interrelations GmbH is not responsible for do not entitle the subscriber to delivery or reimbursement of pre-paid fees.
THE MAGAZINE
European Biotechnology Magazine is a unique source of information about biotechnology in Europe's science and industry sectors. Collaborating with more than 20 national and multinational organisations, our team of highly experienced journalists compiles all the relevant developments into highly readable reports. European Biotechnology Magazine covers all of the 27 EU member states plus Norway, Switzerland and UK. Focusing on the major biotech clusters and renowned European research institutions, as well as the members of national scientific and corporate associations and the biotechnology and Life Sciences industry sector, the highly promising news environment of this journal constitutes timely news from science and industry, background reports on new EU legislation, current debates and financing initiatives from Brussels, as well as market analyses and previews on upcoming technology trends. The magazine is published quarterly.